3-(4-(4-Bromophenyl)-5-((3-methylbenzyl)thio)-4H-1,2,4-triazol-3-yl)pyridine

Catalog No. :
ACGJSL280
CAS No. :
678971-55-6
Molecular Formula :
C21H17BrN4S
Molecular Weight :
437.37

IUPAC Name:3-(4-(4-bromophenyl)-5-((3-methylbenzyl)thio)-4H-1,2,4-triazol-3-yl)pyridine

3-(4-(4-Bromophenyl)-5-((3-methylbenzyl)thio)-4H-1,2,4-triazol-3-yl)pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(4-(4-Bromophenyl)-5-((3-methylbenzyl)thio)-4H-1,2,4-triazol-3-yl)pyridine
IUPAC Name3-(4-(4-bromophenyl)-5-((3-methylbenzyl)thio)-4H-1,2,4-triazol-3-yl)pyridine
MDL No.MFCD03474705
Molecular FormulaC21H17BrN4S
Molecular Weight437.37
SMILESCC1=CC(CSC2=NN=C(C3=CC=CN=C3)N2C4=CC=C(Br)C=C4)=CC=C1
InChI KeyBJJFNKFRTAUIPQ-UHFFFAOYSA-N
SynonymSALOR-INT L407992-1EA;3-(4-(4-BROMOPHENYL)-5-((3-METHYLBENZYL)THIO)-4H-1,2,4-TRIAZOL-3-YL)PYRIDINE;Pyridine, 3-[4-(4-bromophenyl)-5-[[(3-methylphenyl)methyl]thio]-4H-1,2,4-triazol-3-yl]-
CAS No.678971-55-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACGJSL280 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGJSL280 route product structure diagram
    ACGJSL280678971-55-6
Inquiry

2. ACGJSL280 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGJSL280 route product structure diagram
    ACGJSL280678971-55-6
Inquiry

Comments (0)